Reuters logo
BRIEF-Tissue Regenix proposes acquisition of Cellright Technologies
July 20, 2017 / 5:10 PM / 4 months ago

BRIEF-Tissue Regenix proposes acquisition of Cellright Technologies

July 20 (Reuters) - Tissue Regenix Group Plc:

* Says conditional acquisition of Cellright Technologies for total consideration of up to $30.0 million

* Proposed placing and subscription of new ordinary shares at a price of 10 pence per share to raise approximately £40 million

* Says proceeds from offer will be used to finance initial consideration of $25.9 million (£19.9 million) for acquisition Source text for Eikon: [ID:2.79 billion shillings] Further company coverage: (Bangalore.newsroom@thomsonreuters.com)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below